Act4Biosimilars: The Action Plan and Deep Dive Report for Europe are Now Live!
Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater Approvability, Accessibility, Acce...
3rd International Symposium on Pancreatic Cancer
On 16-18 October, French researchers from the AFRCP (Association Française pour la Recherche sur le Cancer du Pancreas) organised the ‘Pancr...
EuropaColon Portugal Launched Support Line for Carers
Europacolon Portugal and Merck Portugal have launched a psychological support line for informal carers.
...
RWE Research in mCRC
In a recent article published in the Future Oncology, Patient Advocates and DiCE CEO Zorana Maravic explored and enhanced the understanding of the ...
Updates in Oesophageal and Gastric Cancer Research, Summer 2023
Results from the phase III ATTRACTION-5 (NCT03006705) study showed that adding nivolumab to adjuvant chemotherapy does not improve relapse-free sur...
Join our Young CRC Patient Focus Group
Join DiCE’s focus group & contribute to our mission of raising awareness about the increasing incidence of colorectal cancer in young Eu...
Shaping Priorities for the EU4Health Funding Programme
The Commission conducted in May a targeted consultation on the EU4Health programme’s future priorities, orientation, and needs. DiCE contribu...
Croatian National Policy Event on Digestive Cancers
As part of DiCE’s campaign for improving health policies in treating digestive cancers, Croatian Member, Iget will organise a hybrid National...
SURVEY: Assessing AI Awareness & Perceptions Among Patient Organisations
European Patient’s Forum (EPF) is collecting responses to a survey addressed to patients’ organisations or individuals carrying out pat...
Kick-Off Event for the SmartCARE Project
On 28 March, key collaborators from the smartCARE consortium gathered in Brussels to share ideas and perspectives. Haidar Akl, a member of our scie...
